AbbVie
The Solid Tumors Commercial Manager at AbbVie will lead both marketing and sales management for core oncology products in Mexico, developing patient‑centric strategies, overseeing brand and field team alignment, and driving sales performance against targets. The role involves strategic planning, cross‑functional collaboration, and execution of omnichannel promotional activities.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
AbbVie didn’t post a salary, so this is our estimate from similar listings.
75% above the average for this role
Sales Manager Solid Tumors (mit eigenem Gebiet, m/w/d)
AbbVie
Director (m/f/d) Marketing Oncology - Solid Tumors
Gilead Sciences
Associate Director, Scientific Communications Lead, Solid Tumors, Global Medical Affairs Oncology
Takeda Pharmaceutical Company Limited
Sales Manager Solid Tumors (mit eigenem Gebiet, m/w/d)
AbbVie
Director/ Sr. Director, Regulatory Affairs (Strategy, Oncology – Solid Tumors)
Nurix
Director, Prostate Cancer and Solid Tumors
Novartis